Inventor
WANG HUI-LING
US35 patents
⚠️ This page may combine multiple inventors who share the name “WANG HUI-LING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMGEN INC
22 patentsUS10640504B2May 5, 2020
Inhibitors of KRAS G12C and methods of using the same
AMGEN INC50 citations97
US10532042B2Jan 14, 2020
KRAS G12C inhibitors and methods of using the same
AMGEN INC49 citations97
US11306087B2Apr 19, 2022
Inhibitors of KRAS G12C and methods of using the same
AMGEN INC16 citations94
US11090304B2Aug 17, 2021
KRAS G12C inhibitors and methods of using the same
AMGEN INC33 citations94
US11285135B2Mar 29, 2022
KRAS G12C inhibitors and methods of using the same
AMGEN INC20 citations93
US7053088B2May 30, 2006
Vanilloid receptor ligands and their use in treatments
AMGEN INC19 citations92
US6822097B1Nov 23, 2004
Compounds and methods of uses
AMGEN INC23 citations91
US12083121B2Sep 10, 2024
Substituted piperazines as KRAS G12C inhibitors
AMGEN INC7 citations85
US11993597B2May 28, 2024
Inhibitors of KRAS G12C and methods of using the same
AMGEN INC8 citations85
US11766436B2Sep 26, 2023
KRAS G12C inhibitors and methods of using the same
AMGEN INC11 citations85
US11285156B2Mar 29, 2022
Substituted piperazines as KRAS G12C inhibitors
AMGEN INC16 citations85
US7119111B2Oct 10, 2006
2-oxo-1,3,4-trihydroquinazolinyl derivatives and methods of use
AMGEN INC11 citations82
US7144888B2Dec 5, 2006
Vanilloid receptor ligands and their use in treatments
AMGEN INC9 citations72
US12440491B2Oct 14, 2025
KRAS G12C inhibitors and methods of using the same
AMGEN INC1 citations64
US12583854B2Mar 24, 2026
KRAS G12C inhibitors and methods of using the same
AMGEN INC0 citations62
US7396831B2Jul 8, 2008
Vanilloid receptor ligands and their use in treatments
AMGEN INC5 citations62
US7534798B2May 19, 2009
Vanilloid receptor ligands and their use in treatments
AMGEN INC4 citations61
US7524874B2Apr 28, 2009
Vanilloid receptor ligands and their use in treatments
AMGEN INC0 citations51
US7511044B2Mar 31, 2009
Vanilloid receptor ligands and their use in treatments
AMGEN INC1 citations50
US7332511B2Feb 19, 2008
Vanilloid receptor ligands and their use in treatments
AMGEN INC0 citations50
US7148221B2Dec 12, 2006
Vanilloid receptor ligands and their use in treatments
AMGEN INC1 citations50
US9394297B2Jul 19, 2016
Amides as pim inhibitors
AMGEN INC0 citations38
TAIWAN SEMICONDUCTOR MFG
7 patentsUS6136680AOct 24, 2000
Methods to improve copper-fluorinated silica glass interconnects
TAIWAN SEMICONDUCTOR MFG133 citations97
US5956609ASep 21, 1999
Method for reducing stress and improving step-coverage of tungsten interconnects and plugs
TAIWAN SEMICONDUCTOR MFG106 citations95
US6407007B1Jun 18, 2002
Method to solve the delamination of a silicon nitride layer from an underlying spin on glass layer
TAIWAN SEMICONDUCTOR MFG21 citations92
US6586347B1Jul 1, 2003
Method and structure to improve the reliability of multilayer structures of FSG (F-doped SiO2) dielectric layers and metal layers in semiconductor integrated circuits
TAIWAN SEMICONDUCTOR MFG16 citations83
US6281146B1Aug 28, 2001
Plasma enhanced chemical vapor deposition (PECVD) method for forming microelectronic layer with enhanced film thickness uniformity
TAIWAN SEMICONDUCTOR MFG14 citations74
US6287172B1Sep 11, 2001
Method for improvement of tungsten chemical-mechanical polishing process
TAIWAN SEMICONDUCTOR MFG10 citations73
US6248002B1Jun 19, 2001
Obtaining the better defect performance of the fuse CMP process by adding slurry polish on more soft pad after slurry polish
TAIWAN SEMICONDUCTOR MFG13 citations73